Overview

Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of capecitabine combined with paclitaxel as neoadjuvant chemotherapy for gastric cancer with liver metastasis only
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Cancer Hospital
Collaborator:
Roche Pharma AG
Treatments:
Albumin-Bound Paclitaxel
Capecitabine
Paclitaxel